CapitalOne Starts Ironwood Pharmaceuticals (IRWD) at Overweight
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $8.08 --0%
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 4
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 4
Join SI Premium – FREE
CapitalOne initiates coverage on Ironwood Pharmaceuticals (NASDAQ: IRWD) with a Overweight rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.
Shares of Ironwood Pharmaceuticals closed at $10.83 yesterday.
You May Also Be Interested In
- DA Davidson Starts Napco Security Technologies, Inc. (NSSC) at Buy
- Craig-Hallum Starts Red Robin Gourmet Burgers (RRGB) at Buy
- Scotiabank Starts Rapid7 (RPD) at Sector Perform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
